OncoSec Medical Inc (ONCSQ)

[ntbiotech]

The eventual data decides which drugs and companies succeed. No company goes into developing drugs thinking how to fool investors. Now there maybe some CeOs that do that. But that could ultimately land them in jail because drug development is playing with lives and malicious intent will ultimately could lead to patient death.

Short investors pray for the drug to fail. Long investors see optimism. Ultimately data decides what prevails. Science can be very good. But ultimate value of a drug comes not from the science but its clinical utility. Science helps drugs get to the clinic where their utility gets tested.